Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment.
暂无分享,去创建一个
[1] N Cascinelli,et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] L. Karnell,et al. The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.
[3] A. Blum,et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment , 1999, The British journal of dermatology.
[4] Jennifer L. Schwartz,et al. Thin primary cutaneous melanomas , 2002, Cancer.
[5] D. Whiteman,et al. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies , 2004, Cancer Causes & Control.
[6] J. Whited,et al. The rational clinical examination. Does this patient have a mole or a melanoma? , 1998, JAMA.
[7] M. Helfand,et al. Counseling to Prevent Skin Cancer: A Summary of the Evidence , 2003 .
[8] D L Morton,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.
[9] M. Perlman,et al. American College of Preventive Medicine practice policy statement: skin protection from ultraviolet light exposure. The American College of Preventive Medicine. , 1998, American journal of preventive medicine.
[10] M. Mihm,et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. , 2000, Annals of surgical oncology.
[11] Robert L. Lawrence,et al. Extending Medicare Coverage for Preventive and Other Services , 2000 .
[12] J. Aitken,et al. A randomised trial of population screening for melanoma , 2002, Journal of medical screening.
[13] M. Perlman,et al. American College of Preventive Medicine policy statement: screening for skin cancer. , 1998, American journal of preventive medicine.
[14] J. Kirkwood,et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] V. Deleo,et al. Prevention of skin cancer. , 1988, The Journal of dermatologic surgery and oncology.
[16] A. Berg. Counseling to prevent skin cancer , 2004 .
[17] J C Briggs,et al. Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.
[18] J. A. Bishop,et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. , 2002, Archives of surgery.
[19] M. Gore,et al. Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. , 2003, Cancer treatment reviews.
[20] Donald R. Miller,et al. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program. , 2002, Cancer.
[21] C. Begg,et al. Screening for cutaneous melanoma by skin self-examination. , 1996, Journal of the National Cancer Institute.
[22] M. Helfand,et al. Screening for skin cancer. , 2001, American journal of preventive medicine.
[23] D. McCready,et al. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity , 2003, Journal of surgical oncology.
[24] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.
[25] Hensin Tsao,et al. A population‐based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors , 2003, Cancer.
[26] E. Gershenwald. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy , 2007, Annals of Surgical Oncology.
[27] Raymond L. Barnhill,et al. Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas , 2001, Annals of Surgical Oncology.
[28] E. Holly,et al. Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.
[29] A. Kopf,et al. Early detection of malignant melanoma: The role of physician examination and self‐examination of the skin , 1985, CA: a cancer journal for clinicians.
[30] K. Glanz,et al. Preventing skin cancer: findings of the Task Force on Community Preventive Services On reducing Exposure to Ultraviolet Light. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[31] G. Plewig,et al. Risk of second primary malignancies in patients with cutaneous melanoma , 2001, The British journal of dermatology.
[32] M. Mihm,et al. Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm) , 2000, Annals of Surgical Oncology.
[33] D. Rigel,et al. Malignant melanoma: Prevention, early detection, and treatment in the 21st century , 2000, CA: a cancer journal for clinicians.
[34] Michael Binder,et al. Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk , 2003, Melanoma research.